Airexar Spiromax 欧州連合 - デンマーク語 - EMA (European Medicines Agency)

airexar spiromax

teva b.v. - salmeterol, fluticasonpropionat - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - airexar spiromax er indiceret til brug kun hos voksne i alderen 18 år og ældre. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. kronisk obstruktiv lungesygdom (kol)airexar spiromax er indiceret til symptomatisk behandling af patienter med kol med fev1.

AirFluSal Sprayhaler 25+250 mikrog./dosis inhalationsspray, suspension デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

airflusal sprayhaler 25+250 mikrog./dosis inhalationsspray, suspension

sandoz a/s - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog./dosis

Airflusal Aerosol 25+250 mikrog./dosis inhalationsspray, suspension デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

airflusal aerosol 25+250 mikrog./dosis inhalationsspray, suspension

2care4 aps - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog./dosis

BroPair Spiromax 欧州連合 - デンマーク語 - EMA (European Medicines Agency)

bropair spiromax

teva b.v. - salmeterol xinafoate, fluticasonpropionat - astma - medicin for obstruktiv sygdomme, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.